Xiang Li

Xiang Li is a Research Associate Professor in the Department of Pharmacological and Pharmaceutical Sciences at the University of Houston College of Pharmacy. Their research focuses on vascular pathobiology, particularly the cellular and molecular mechanisms underlying atherosclerosis, hypertension, and arterial stiffness associated with obesity, aging, and chronic kidney disease.

• M.D. in Clinical Medicine, Peking University
• M.S. in Pharmacology & Toxicology, Medical College of Wisconsin
• Ph.D. in Molecular Biology, University of Duisburg-Essen

Research interests include epigenetic regulation, lipid biology, redox signaling, vascular inflammation, cell senescence, and progenitor cell dynamics. Their work utilizes gene knockout models, surgical interventions, and adenoviral gene delivery techniques to investigate disease mechanisms.

Recent publications highlight trends in lysosome biogenesis, inflammasome activation, TFEB signaling, and acid sphingomyelinase roles in vascular dysfunction. Key themes span atherosclerosis, diabetes-related vascular complications, and inflammatory pathways.

• National Heart Lung Blood Institute Early Stage Investigator (2021)
• DFG Predoctoral Fellowship (2008-2010)
• Forschungstag Posterpreis (2008)

Contact: xli59@uh.edu